We thank van Delft et al.[
[1]
] for their letter to the Editor related to our published European consensus-based
interdisciplinary guidelines on the diagnosis and treatment of basal cell carcinoma
(BCC) [
[2]
]. They comment on the extensive safety margins for conventional (2D) surgical excision
of high-risk BCCs and the proposed frequent follow-up of patients with a history of
BCC.- Peris K.
- Fargnoli M.C.
- Garbe C.
- Kaufmann R.
- Bastholt L.
- Seguin N.B.
- et al.
European Dermatology Forum (EDF), the European association of dermato-oncology (EADO)
and the European organization for research and treatment of cancer (EORTC). Diagnosis
and treatment of basal cell carcinoma: European consensus-based interdisciplinary
guidelines.
Eur J Canc. 2019; 118: 10-34
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Comment on "Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.Eur J Canc. 2020 Jan 10; (pii: S0959-8049(19)30853-30856)
- European Dermatology Forum (EDF), the European association of dermato-oncology (EADO) and the European organization for research and treatment of cancer (EORTC). Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.Eur J Canc. 2019; 118: 10-34
- Access to innovative medicines for metastatic melanoma worldwide: melanoma World Society and European Association of Dermato-oncology survey in 34 countries.Eur J Canc. 2018; 104: 201-209
- S2kguidelines for cutaneous basal cell carcinoma - Part 2: treatment, prevention and follow-up.J Dtsch Dermatol Ges. 2019; 17: 214-230
Article info
Publication history
Published online: March 30, 2020
Accepted:
February 19,
2020
Received:
February 17,
2020
Identification
Copyright
© 2020 Elsevier Ltd. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Comment on “Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines”European Journal of CancerVol. 131
- PreviewThe European interdisciplinary guidelines on the diagnosis and treatment of basal cell carcinoma (BCC) are a thorough updated and expanded review of the literature [1]. The guidelines provide guidance for physicians to optimise BCC care. We strongly agree with emphasising personalised care and an individualised approach for each patient and tumour. In addition, we would like to comment on the extensive safety margins advised for conventional (2D) surgical excision of high-risk BCCs and the proposed frequent follow-up of patients with a history of BCC.
- Full-Text
- Preview
- Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelinesEuropean Journal of CancerVol. 118
- PreviewBasal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization of Research and Treatment of Cancer collaborated to develop recommendations on diagnosis and treatment of BCC. A new classification into ‘easy-to-treat (common) BCC and ‘difficult-to-treat’ BCC is proposed. Diagnosis is based on clinicodermatoscopic features for ‘easy-to-treat’ BCCs.
- Full-Text
- Preview
